tiprankstipranks
Advertisement
Advertisement

PCVX Stock Latest News

Vaxcyte reports Q1 EPS ($2.30), consensus ($1.77)
The FlyVaxcyte reports Q1 EPS ($2.30), consensus ($1.77)
19d ago
PCVX
Vaxcyte completes enrollment in Vaxcyte VAX-31 OPUS-1 trial
PremiumThe Fly
Vaxcyte completes enrollment in Vaxcyte VAX-31 OPUS-1 trial
2M ago
PCVX
Vaxcyte reports positive VAX-31 phase 1/2 adult data published in The Lancet
PremiumThe Fly
Vaxcyte reports positive VAX-31 phase 1/2 adult data published in The Lancet
2M ago
PCVX
Vaxcyte Earnings Call: Cash Strength, Trials Accelerate
PremiumCompany Announcements
Vaxcyte Earnings Call: Cash Strength, Trials Accelerate
3M ago
PCVX
Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans
PremiumCompany Announcements
Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans
3M ago
PCVX
Vaxcyte: Buy Rated on Superior VAX-31 Coverage, Robust Phase 3 OPUS Program, and Strong Cash Runway Through 2028
PremiumRatingsVaxcyte: Buy Rated on Superior VAX-31 Coverage, Robust Phase 3 OPUS Program, and Strong Cash Runway Through 2028
3M ago
PCVX
Vaxcyte price target raised to $89 from $85 at BTIG
Premium
The Fly
Vaxcyte price target raised to $89 from $85 at BTIG
3M ago
PCVX
Vaxcyte price target lowered to $133 from $134 at BofA
Premium
The Fly
Vaxcyte price target lowered to $133 from $134 at BofA
3M ago
PCVX
Vaxcyte price target raised to $67 from $38 at Goldman Sachs
PremiumThe Fly
Vaxcyte price target raised to $67 from $38 at Goldman Sachs
3M ago
PCVX
Vaxcyte price target raised to $75 from $50 at TD Cowen
PremiumThe Fly
Vaxcyte price target raised to $75 from $50 at TD Cowen
3M ago
PCVX
Vaxcyte Launches New $500 Million ATM Equity Program
PremiumCompany Announcements
Vaxcyte Launches New $500 Million ATM Equity Program
3M ago
8K
PCVX
Vaxcyte reports Q4 EPS ($5.63) vs ($3.80) last year
PremiumThe Fly
Vaxcyte reports Q4 EPS ($5.63) vs ($3.80) last year
3M ago
PCVX
Is PCVX a Buy, Before Earnings?
PremiumPre-EarningsIs PCVX a Buy, Before Earnings?
3M ago
PCVX
Vaxcyte’s VAX-31 Moves Into Phase 3: What This Pneumococcal Vaccine Update Means for PCVX Investors
Premium
Company Announcements
Vaxcyte’s VAX-31 Moves Into Phase 3: What This Pneumococcal Vaccine Update Means for PCVX Investors
3M ago
PCVX
Vaxcyte doses first participants in OPUS-3 trial
Premium
The Fly
Vaxcyte doses first participants in OPUS-3 trial
3M ago
PCVX
Vaxcyte Completes Public Equity Offering, Bolstering Capital Position
PremiumCompany Announcements
Vaxcyte Completes Public Equity Offering, Bolstering Capital Position
4M ago
8K
PCVX
Vaxcyte 11M share Spot Secondary priced at $50.00
PremiumThe Fly
Vaxcyte 11M share Spot Secondary priced at $50.00
4M ago
PCVX
Vaxcyte secondary being re-offered at $50 per share
PremiumThe Fly
Vaxcyte secondary being re-offered at $50 per share
4M ago
PCVX
Vaxcyte offering marketed at $50 per share, Bloomberg says
PremiumThe Fly
Vaxcyte offering marketed at $50 per share, Bloomberg says
4M ago
PCVX
Vaxcyte announces offering of $500M of common stock and warrants
PremiumThe FlyVaxcyte announces offering of $500M of common stock and warrants
4M ago
PCVX
Vaxcyte provides update on development of VAX-31 pneumococcal vaccine
Premium
The Fly
Vaxcyte provides update on development of VAX-31 pneumococcal vaccine
4M ago
PCVX
Needham ups Vaxcyte target, adds to Conviction List
Premium
The Fly
Needham ups Vaxcyte target, adds to Conviction List
5M ago
PCVX
PHAT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >